Rubric Capital Management LP - Q2 2021 holdings

$1.59 Billion is the total value of Rubric Capital Management LP's 63 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 100.0% .

 Value Shares↓ Weighting
CVM ExitCEL-SCI CORPput$0-160,000
-100.0%
-0.14%
QNST ExitQUINSTREET INC$0-227,115
-100.0%
-0.27%
PAE ExitPAE INC$0-544,033
-100.0%
-0.29%
AERI ExitAERIE PHARMACEUTICALS INC$0-480,402
-100.0%
-0.50%
LTRPA ExitLIBERTY TRIPADVISOR HLDGS IN$0-2,322,912
-100.0%
-0.87%
VNT ExitVONTIER CORPORATION$0-494,336
-100.0%
-0.87%
ESGC ExitEROS STX GLOBAL CORPORATION$0-10,500,000
-100.0%
-1.11%
UFS ExitDOMTAR CORP$0-575,291
-100.0%
-1.24%
EXTR ExitEXTREME NETWORKS INC$0-2,458,110
-100.0%
-1.26%
DEN ExitDENBURY INC$0-507,042
-100.0%
-1.42%
BIDU ExitBAIDU INCspon adr rep a$0-115,261
-100.0%
-1.46%
AVID ExitAVID TECHNOLOGY INC$0-1,203,156
-100.0%
-1.48%
MRNA ExitMODERNA INCput$0-200,000
-100.0%
-1.53%
AEL ExitAMERICAN EQTY INVT LIFE HLD$0-1,000,000
-100.0%
-1.84%
USFD ExitUS FOODS HLDG CORP$0-1,125,461
-100.0%
-2.51%
THC ExitTENET HEALTHCARE CORP$0-883,258
-100.0%
-2.68%
MIC ExitMACQUARIE INFRASTRUCTURE COR$0-1,464,961
-100.0%
-2.72%
APO ExitAPOLLO GLOBAL MGMT INC$0-1,140,274
-100.0%
-3.13%
RXT ExitRACKSPACE TECHNOLOGY INC$0-2,300,000
-100.0%
-3.20%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-08-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MAGNACHIP SEMICONDUCTOR CORP28Q3 20234.7%
BGC PARTNERS INC20Q2 20234.6%
MR COOPER GROUP INC20Q3 20235.9%
PAR PACIFIC HOLDINGS INC18Q3 20233.9%
RADIUS HEALTH INC16Q2 20224.3%
CLEAR CHANNEL OUTDOOR HLDGS16Q3 20232.6%
HERON THERAPEUTICS INC15Q3 20239.0%
COLLEGIUM PHARMACEUTICAL INC15Q3 20233.9%
AAR CORP14Q3 20233.2%
GREEN PLAINS INC14Q3 20224.1%

View Rubric Capital Management LP's complete holdings history.

Latest significant ownerships (13-D/G)
Rubric Capital Management LP Q2 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
HERON THERAPEUTICS, INC. /DE/July 25, 202326,713,50319.0%
Amryt Pharma plcFebruary 10, 202318,000,0005.6%
BGC Partners, Inc.February 10, 202318,250,0005.6%
EverQuote, Inc.February 10, 20231,246,6224.8%
Ferroglobe PLCFebruary 10, 20233,232,7621.7%
Sio Gene Therapies Inc.February 10, 20237,000,0009.5%
Vincerx Pharma, Inc.February 10, 2023386,7191.8%
Whole Earth Brands, Inc.February 10, 2023998,3632.4%
Radius Health, Inc.June 16, 20226,959,30514.6%
ANTARES PHARMA, INC.February 14, 202210,800,0006.4%

View Rubric Capital Management LP's complete significant-ownership history.

Latest filings
TypeFiled
DFAN14A2024-05-16
13F-HR2024-05-10
DFAN14A2024-05-08
DFAN14A2024-05-03
DFAN14A2024-05-01
DFAN14A2024-04-30
DFAN14A2024-04-29
DEFC14A2024-04-17
DFAN14A2024-04-17
SC 13D/A2024-04-16

View Rubric Capital Management LP's complete filings history.

Compare quarters

Export Rubric Capital Management LP's holdings